|
JPH10506126A
(ja)
|
1995-05-12 |
1998-06-16 |
ニューロゲン コーポレイション |
新規なデアザプリン誘導体；ｃｒｆ１特異性リガンドの新規なクラス
|
|
US6313124B1
(en)
|
1997-07-23 |
2001-11-06 |
Dupont Pharmaceuticals Company |
Tetrazine bicyclic compounds
|
|
US6124289A
(en)
*
|
1996-07-24 |
2000-09-26 |
Dupont Pharmaceuticals Co. |
Azolo triazines and pyrimidines
|
|
US6191131B1
(en)
|
1997-07-23 |
2001-02-20 |
Dupont Pharmaceuticals Company |
Azolo triazines and pyrimidines
|
|
US6060478A
(en)
*
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
|
US7094782B1
(en)
|
1996-07-24 |
2006-08-22 |
Bristol-Myers Squibb Company |
Azolo triazines and pyrimidines
|
|
JP2001511813A
(ja)
|
1997-02-18 |
2001-08-14 |
ニューロクライン バイオサイエンシーズ，インコーポレイテッド |
Ｃｒｆレセプターアンタゴニストおよびそれらに関連する方法
|
|
NZ335823A
(en)
|
1997-04-22 |
2001-06-29 |
Neurocrine Biosciences Inc |
Thiophenopyridines, preparation as CRF receptor antagonists
|
|
JP2002507996A
(ja)
*
|
1997-07-03 |
2002-03-12 |
デュポン ファーマシューティカルズ カンパニー |
神経学的障害を治療するためのイミダゾピリミジン類およびイミダゾピリジン類
|
|
IL137019A0
(en)
*
|
1998-01-28 |
2001-06-14 |
Du Pont Pharm Co |
Azolo triazines and pyrimidines
|
|
US6187777B1
(en)
*
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
EP1068205A1
(en)
|
1998-04-02 |
2001-01-17 |
Neurogen Corporation |
Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino 2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino 4,5-b]indole derivatives: crf1 specific ligands
|
|
US6472402B1
(en)
|
1998-04-02 |
2002-10-29 |
Neurogen Corporation |
Aminoalkyl substituted 5,6,7,8-Tetrahydro-9H-Pyridino [2,3-B]indole derivatives
|
|
WO1999051608A1
(en)
*
|
1998-04-03 |
1999-10-14 |
Du Pont Pharmaceuticals Company |
THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
|
|
AU4556999A
(en)
*
|
1998-06-09 |
1999-12-30 |
Neurogen Corporation |
Pyrido[2,3-b]indolizine derivatives and aza analogues thereof; crf1 specific ligands
|
|
US6509338B1
(en)
|
1998-06-22 |
2003-01-21 |
Bristol-Myers Squibb Company |
Pyrazolo[1,5-A]triazine corticotropin releasing factor antagonists
|
|
CA2339188A1
(en)
*
|
1998-08-21 |
2000-03-02 |
Dupont Pharmaceuticals Company |
Isoxazolo¬4,5-d|pyrimidines as crf antagonists
|
|
US6531475B1
(en)
*
|
1998-11-12 |
2003-03-11 |
Neurocrine Biosciences, Inc. |
CRF receptor antagonists and methods relating thereto
|
|
CA2349904A1
(en)
|
1998-11-12 |
2000-05-18 |
Neurocrine Biosciences, Inc. |
Crf receptor antagonists and methods relating thereto
|
|
DK1129091T3
(da)
|
1998-11-12 |
2002-11-04 |
Neurocrine Biosciences Inc |
Antagonister for CRF-receptorer og fremgangsmåder med relation dertil
|
|
AU2321000A
(en)
*
|
1999-01-29 |
2000-08-18 |
Sumitomo Chemical Company, Limited |
Fat accumulation inhibitory agents
|
|
EP1040831A3
(en)
*
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
|
|
AU4331500A
(en)
|
1999-04-06 |
2000-10-23 |
Du Pont Pharmaceuticals Company |
Pyrazolotriazines as crf antagonists
|
|
AU4203500A
(en)
|
1999-04-06 |
2000-10-23 |
Du Pont Pharmaceuticals Company |
Pyrazolopyrimidines as crf antagonists
|
|
US6982265B1
(en)
|
1999-05-21 |
2006-01-03 |
Bristol Myers Squibb Company |
Pyrrolotriazine inhibitors of kinases
|
|
EP1669071B1
(en)
*
|
1999-05-21 |
2009-07-22 |
Bristol-Myers Squibb Company |
Pyrrolotriazine inhibitors of kinases
|
|
US6432989B1
(en)
*
|
1999-08-27 |
2002-08-13 |
Pfizer Inc |
Use of CRF antagonists to treat circadian rhythm disorders
|
|
AU7738000A
(en)
|
1999-09-30 |
2001-04-30 |
Neurogen Corporation |
Certain alkylene diamine-substituted heterocycles
|
|
PL354675A1
(en)
|
1999-09-30 |
2004-02-09 |
Neurogen Corporation |
Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
|
|
SE9903544D0
(sv)
*
|
1999-10-01 |
1999-10-01 |
Astra Pharma Prod |
Novel compounds
|
|
IL139197A0
(en)
|
1999-10-29 |
2001-11-25 |
Pfizer Prod Inc |
Use of corticotropin releasing factor antagonists and related compositions
|
|
TWI271406B
(en)
|
1999-12-13 |
2007-01-21 |
Eisai Co Ltd |
Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
|
|
DE60101372T2
(de)
*
|
2000-02-11 |
2004-10-14 |
Astrazeneca Ab |
Pyrimidinverbindungen und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität
|
|
GB2359078A
(en)
*
|
2000-02-11 |
2001-08-15 |
Astrazeneca Uk Ltd |
Pharmaceutically active pyrimidine derivatives
|
|
GB2359081A
(en)
|
2000-02-11 |
2001-08-15 |
Astrazeneca Uk Ltd |
Pharmaceutically active thiazolopyrimidines
|
|
KR20030016222A
(ko)
*
|
2000-02-14 |
2003-02-26 |
니뽄 다바코 산교 가부시키가이샤 |
수술후 스트레스 예방ㆍ치료제
|
|
GB2359551A
(en)
|
2000-02-23 |
2001-08-29 |
Astrazeneca Uk Ltd |
Pharmaceutically active pyrimidine derivatives
|
|
EP1149583A3
(en)
*
|
2000-04-13 |
2001-11-14 |
Pfizer Products Inc. |
Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
|
|
JP2003533530A
(ja)
|
2000-05-18 |
2003-11-11 |
ニューロクライン バイオサイエンシーズ， インコーポレイテッド |
Ｃｒｆレセプターアンタゴニスト
|
|
MXPA02010763A
(es)
|
2000-06-14 |
2003-03-10 |
Warner Lambert Co |
Heterociclicos biciclos-6,5 fusionados.
|
|
US6630476B2
(en)
|
2000-07-07 |
2003-10-07 |
Bristol-Myers Squibb Pharma Company |
Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
|
|
SE0003828D0
(sv)
|
2000-10-20 |
2000-10-20 |
Astrazeneca Ab |
Novel compounds
|
|
US6867300B2
(en)
|
2000-11-17 |
2005-03-15 |
Bristol-Myers Squibb Company |
Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
|
|
AU2002226674B2
(en)
|
2000-12-28 |
2007-03-22 |
Ono Pharmaceutical Co., Ltd. |
Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
|
|
GB0100624D0
(en)
*
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical compounds VII
|
|
TWI312347B
(en)
|
2001-02-08 |
2009-07-21 |
Eisai R&D Man Co Ltd |
Bicyclic nitrogen-containing condensed ring compounds
|
|
ES2282401T3
(es)
*
|
2001-03-13 |
2007-10-16 |
Bristol-Myers Squibb Pharma Company |
4-(2-butilamino)-2,7-dimetil-8-(2-metil-6-metoxipirid-3-il) pirazolo - 1,5-a-1,3,5-triazina, sus enantiomeros y sales farmaceuticamente aceptables como ligandos del receptor del factor liberador de croticotropina.
|
|
SE0101322D0
(sv)
|
2001-04-12 |
2001-04-12 |
Astrazeneca Ab |
Novel compounds
|
|
BR0209252A
(pt)
|
2001-04-27 |
2004-07-20 |
Eisai Co Ltd |
Pirazolo[1,5-a]piridinas e medicamentos contendo as mesmas
|
|
PL367771A1
(en)
*
|
2001-05-21 |
2005-03-07 |
Neurocrine Biosciences Inc. |
Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
|
|
GB0117396D0
(en)
|
2001-07-17 |
2001-09-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
|
TW200300350A
(en)
|
2001-11-14 |
2003-06-01 |
Bristol Myers Squibb Co |
C-5 modified indazolylpyrrolotriazines
|
|
ATE302203T1
(de)
|
2002-03-07 |
2005-09-15 |
Smithkline Beecham Corp |
Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen
|
|
ATE478872T1
(de)
*
|
2002-03-28 |
2010-09-15 |
Ustav Ex Botan Av Cr V V I I O |
Pyrazoloä4,3-düpyrimidine, verfahren zu ihrer herstellung und therapeutische anwendung
|
|
US7119200B2
(en)
*
|
2002-09-04 |
2006-10-10 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
GB0221828D0
(en)
|
2002-09-20 |
2002-10-30 |
Astrazeneca Ab |
Novel compound
|
|
AR041470A1
(es)
*
|
2002-10-17 |
2005-05-18 |
Upjohn Co |
Compuestos de pirrolo (1,2 - b) piridazina y sus usos
|
|
AU2003275589B2
(en)
|
2002-10-22 |
2009-05-28 |
Eisai R & D Management Co., Ltd. |
7-phenyl pyrazolopyridine compounds
|
|
US7176216B2
(en)
|
2002-10-22 |
2007-02-13 |
Eisai Co., Ltd. |
7-phenylpyrazolopyridine compounds
|
|
TW200420565A
(en)
|
2002-12-13 |
2004-10-16 |
Bristol Myers Squibb Co |
C-6 modified indazolylpyrrolotriazines
|
|
RS20050532A
(sr)
|
2003-01-14 |
2007-12-31 |
Arena Pharmaceuticals Inc., |
Derivati 1,2,3-trisupstituisanog arila i heteroarila kao modulatori metabolizma za profilaksu i tretman poremećaja povezanih sa njim, kao što su dijebetes i hiperglikemija
|
|
UA81453C2
(en)
*
|
2003-02-27 |
2008-01-10 |
|
Pyrazolopyridine derivates
|
|
US7041671B2
(en)
|
2003-04-02 |
2006-05-09 |
Pfizer Inc |
Pyrrolo[1,2-b]pyridazine compounds and their uses
|
|
US7034023B2
(en)
*
|
2003-04-04 |
2006-04-25 |
Pfizer Inc |
Pyrrolo[1,2-B]pyridazine compounds and their uses
|
|
US7056920B2
(en)
|
2003-04-04 |
2006-06-06 |
Pfizer Inc |
Pyrrolo[1,2-B]pyridazine compounds and their uses
|
|
GB0308208D0
(en)
|
2003-04-09 |
2003-05-14 |
Glaxo Group Ltd |
Chemical compounds
|
|
BRPI0409444A
(pt)
*
|
2003-04-15 |
2006-04-18 |
Pharmacia & Upjohn Co Llc |
compostos de pirrolo[1,2-b]piridazina e suas utilizações
|
|
KR100824193B1
(ko)
|
2003-04-29 |
2008-04-21 |
화이자 인코포레이티드 |
고혈압 치료에 유용한5,7-디아미노피라졸로[4,3-ｄ]피리미딘
|
|
JP2006525309A
(ja)
*
|
2003-05-07 |
2006-11-09 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
ピロロ（１，２−ｂ）ピリダジン化合物、ならびにＣＲＦ−１受容体拮抗薬としてのその使用
|
|
WO2004110454A1
(ja)
*
|
2003-06-13 |
2004-12-23 |
Ishihara Sangyo Kaisha, Ltd. |
アデノシンＡ2ａ受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物
|
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
|
KR20060056944A
(ko)
|
2003-07-14 |
2006-05-25 |
아레나 파마슈티칼스, 인크. |
대사 조절제로서 융합된 아릴 및 헤테로아릴 유도체 및이에 관련된 장애의 예방 또는 치료
|
|
EA200600372A1
(ru)
*
|
2003-09-05 |
2006-08-25 |
Ньюроджин Корпорейшн |
Конденсированные с гетероарилом пиридины, пиразины и пиримидины в качестве лигандов рецептора кортикотропин-рилизинг-фактора (crf 1)
|
|
US7153961B2
(en)
|
2003-11-25 |
2006-12-26 |
Bristol-Myers Squibb Pharma Co. |
Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist
|
|
US7208596B2
(en)
|
2003-11-25 |
2007-04-24 |
Bristol-Myers Squibb Pharma Company |
Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
|
|
GB0328243D0
(en)
|
2003-12-05 |
2004-01-07 |
Astrazeneca Ab |
Methods
|
|
US7102001B2
(en)
|
2003-12-12 |
2006-09-05 |
Bristol-Myers Squibb Company |
Process for preparing pyrrolotriazine
|
|
JP4926720B2
(ja)
|
2003-12-22 |
2012-05-09 |
スミスクライン ビーチャム （コーク） リミテッド |
Ｃｒｆ受容体アンタゴニストおよびそれらに関連する方法
|
|
MY145634A
(en)
|
2003-12-29 |
2012-03-15 |
Bristol Myers Squibb Co |
Pyrrolotriazine compounds as kinase inhibitors
|
|
US7064203B2
(en)
|
2003-12-29 |
2006-06-20 |
Bristol Myers Squibb Company |
Di-substituted pyrrolotriazine compounds
|
|
JP2007517793A
(ja)
|
2004-01-06 |
2007-07-05 |
大正製薬株式会社 |
環状アミノ基によって置換されたチエノピリミジン及びチエノピリジン誘導体
|
|
JP4742273B2
(ja)
*
|
2004-01-06 |
2011-08-10 |
大正製薬株式会社 |
ピロロピリミジン及びピロロトリアジン誘導体
|
|
CN1922174A
(zh)
|
2004-02-20 |
2007-02-28 |
贝林格尔·英格海姆国际有限公司 |
病毒聚合酶抑制剂
|
|
US7102002B2
(en)
|
2004-06-16 |
2006-09-05 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
US7102003B2
(en)
|
2004-07-01 |
2006-09-05 |
Bristol-Myers Squibb Company |
Pyrrolotriazine compounds
|
|
US7504521B2
(en)
|
2004-08-05 |
2009-03-17 |
Bristol-Myers Squibb Co. |
Methods for the preparation of pyrrolotriazine compounds
|
|
TW200618803A
(en)
|
2004-08-12 |
2006-06-16 |
Bristol Myers Squibb Co |
Process for preparing pyrrolotriazine aniline compounds useful as kinase inhibitors
|
|
GB0519957D0
(en)
|
2005-09-30 |
2005-11-09 |
Sb Pharmco Inc |
Chemical compound
|
|
US7652035B2
(en)
*
|
2004-10-19 |
2010-01-26 |
Neurocrine Bioscience, Inc. |
CRF receptor antagonists and methods relating thereto
|
|
US7151176B2
(en)
|
2004-10-21 |
2006-12-19 |
Bristol-Myers Squibb Company |
Pyrrolotriazine compounds
|
|
AU2005302448B2
(en)
|
2004-10-29 |
2012-07-19 |
Biocryst Pharmaceuticals, Inc. |
Therapeutic furopyrimidines and thienopyrimidines
|
|
US7674822B2
(en)
|
2004-11-24 |
2010-03-09 |
Wyeth |
PTP1b inhibitors
|
|
CA2602533A1
(en)
|
2005-03-29 |
2006-10-05 |
Biocryst Pharmaceuticals, Inc. |
Use of c-nucleoside analogs for treatment of hepatitis c related viral infections
|
|
JPWO2006126718A1
(ja)
*
|
2005-05-27 |
2008-12-25 |
田辺三菱製薬株式会社 |
ピラゾロピリミジン誘導体
|
|
TW200740820A
(en)
|
2005-07-05 |
2007-11-01 |
Takeda Pharmaceuticals Co |
Fused heterocyclic derivatives and use thereof
|
|
US7932257B2
(en)
|
2005-07-22 |
2011-04-26 |
Sunesis Pharmaceuticals, Inc. |
Substituted pyrazolo[4,3-d]pyrimidines as aurora kinase inhibitors
|
|
US20070078136A1
(en)
|
2005-09-22 |
2007-04-05 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
US7514435B2
(en)
|
2005-11-18 |
2009-04-07 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
US8063208B2
(en)
|
2006-02-16 |
2011-11-22 |
Bristol-Myers Squibb Company |
Crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
|
|
MX2009003098A
(es)
|
2006-09-20 |
2009-04-01 |
Lilly Co Eli |
Compuestos de tiofen pirazolopirimidina.
|
|
KR101088239B1
(ko)
|
2006-09-20 |
2011-11-30 |
일라이 릴리 앤드 캄파니 |
Ｃｒｆ１ 수용체 길항제로서의 티아졸 피라졸로피리미딘
|
|
ES2627352T3
(es)
|
2006-10-19 |
2017-07-27 |
Signal Pharmaceuticals, Llc |
Compuestos heteroarilo, sus composiciones y su uso como inhibidores de proteínas quinasas
|
|
RU2010129928A
(ru)
|
2007-12-19 |
2012-01-27 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Пиразоло[1, 5-а]пиримидины, используемые в качестве ингибиторов jak2
|
|
WO2009126861A2
(en)
|
2008-04-11 |
2009-10-15 |
Bristol-Myers Squibb Company |
Triazolopyridine compounds useful as dgat1 inhibitors
|
|
US8324241B2
(en)
|
2008-04-11 |
2012-12-04 |
Bristol-Myers Squibb Company |
Triazolo compounds useful as DGAT1 inhibitors
|
|
MY152687A
(en)
|
2008-04-15 |
2014-10-31 |
Eisai R&D Man Co Ltd |
3-phenylpyrazolo[5,1-b]thiazole compound
|
|
GB0906579D0
(en)
|
2009-04-16 |
2009-05-20 |
Vernalis R&D Ltd |
Pharmaceuticals, compositions and methods of making and using the same
|
|
TWI491610B
(zh)
|
2008-10-09 |
2015-07-11 |
必治妥美雅史谷比公司 |
作為激酶抑制劑之咪唑并嗒腈
|
|
AR078521A1
(es)
|
2009-10-08 |
2011-11-16 |
Eisai R&D Man Co Ltd |
Compuesto pirazolotiazol
|
|
JP2013519719A
(ja)
*
|
2010-02-18 |
2013-05-30 |
セントロ ナシオナル デ インベスティガシオネス オンコロヒカス（セエネイオ） |
トリアゾロ［４，５−ｂ］ピリジン誘導体
|
|
US8912184B1
(en)
|
2010-03-01 |
2014-12-16 |
Alzheimer's Institute Of America, Inc. |
Therapeutic and diagnostic methods
|
|
MX2012012059A
(es)
*
|
2010-04-16 |
2013-03-21 |
Abbvie Inc |
Inhibidores de pirrolopirazinona de cinasas.
|
|
WO2011137155A1
(en)
|
2010-04-28 |
2011-11-03 |
Bristol-Myers Squibb Company |
Imidazopyridazinyl compounds and their uses for cancer
|
|
TWI541243B
(zh)
|
2010-09-10 |
2016-07-11 |
拜耳知識產權公司 |
經取代咪唑并嗒
|
|
CN103221410B
(zh)
|
2010-09-22 |
2017-09-15 |
艾尼纳制药公司 |
Gpr119受体调节剂和对与其相关的障碍的治疗
|
|
JP2013542259A
(ja)
|
2010-11-12 |
2013-11-21 |
ブリストル−マイヤーズ スクイブ カンパニー |
置換アザインダゾール化合物
|
|
US9284317B2
(en)
|
2010-12-17 |
2016-03-15 |
Bayer Intellectual Property Gmbh |
Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors
|
|
WO2012080232A1
(en)
|
2010-12-17 |
2012-06-21 |
Bayer Pharma Aktiengesellschaft |
2-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
|
|
CA2821829A1
(en)
|
2010-12-17 |
2012-06-21 |
Bayer Intellectual Property Gmbh |
Imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
|
|
ES2691745T3
(es)
|
2011-04-08 |
2018-11-28 |
Janssen Sciences Ireland Uc |
Derivados de pirimidina para el tratamiento de infecciones víricas
|
|
WO2012149157A2
(en)
*
|
2011-04-26 |
2012-11-01 |
Bioenergenix |
Heterocyclic compounds for the inhibition of pask
|
|
WO2013049263A1
(en)
|
2011-09-27 |
2013-04-04 |
Bristol-Myers Squibb Company |
Substituted bicyclic heteroaryl compounds
|
|
DK2776439T3
(en)
|
2011-11-09 |
2018-10-22 |
Janssen Sciences Ireland Uc |
PURINE DERIVATIVES FOR TREATING VIRUS INFECTIONS
|
|
JP6166289B2
(ja)
|
2012-03-14 |
2017-07-19 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ |
置換イミダゾピリダジン
|
|
AU2013289284B2
(en)
*
|
2012-07-09 |
2017-03-30 |
Janssen Pharmaceutica Nv |
Inhibitors of phosphodiesterase 10 enzyme
|
|
DK2872515T3
(en)
|
2012-07-13 |
2016-09-19 |
Janssen Sciences Ireland Uc |
MACROCYCLIC PURINES FOR TREATING VIRUS INFECTIONS
|
|
WO2014020041A1
(en)
|
2012-08-02 |
2014-02-06 |
Bayer Pharma Aktiengesellschaft |
Combinations for the treatment of cancer
|
|
MX386924B
(es)
|
2012-10-10 |
2025-03-19 |
Janssen Sciences Ireland Uc |
Derivados pirrolo[3,2-d]pirimidínicos para el tratamiento de infecciones víricas y otras enfermedades.
|
|
WO2014066743A1
(en)
|
2012-10-25 |
2014-05-01 |
Bioenergenix |
Heterocyclic compounds for the inhibition of pask
|
|
WO2014066795A1
(en)
|
2012-10-25 |
2014-05-01 |
Bioenergenix |
Heterocyclic compounds for the inhibition of pask
|
|
US9663474B2
(en)
|
2012-11-16 |
2017-05-30 |
Janssen Sciences Ireland Uc |
Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections
|
|
KR102300861B1
(ko)
|
2013-02-21 |
2021-09-10 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
바이러스 감염의 치료를 위한 2-아미노피리미딘 유도체
|
|
RU2015143517A
(ru)
|
2013-03-13 |
2017-04-19 |
Дженентек, Инк. |
Пиразолсодержащие соединения и их применения
|
|
WO2014154859A1
(en)
|
2013-03-29 |
2014-10-02 |
Janssen R&D Ireland |
Macrocyclic deaza-purinones for the treatment of viral infections
|
|
UA117586C2
(uk)
|
2013-05-24 |
2018-08-27 |
ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі |
Похідні піридину для лікування вірусних інфекцій та інших захворювань
|
|
CA2914745A1
(en)
|
2013-06-11 |
2014-12-18 |
Bayer Pharma Aktiengesellschaft |
Prodrug derivatives of substituted triazolopyridines
|
|
MX392130B
(es)
|
2013-06-27 |
2025-03-21 |
Janssen Sciences Ireland Uc |
Derivados de pirrolo[3,2-d]pirimidina para el tratamiento de infecciones víricas y otras enfermedades.
|
|
ES2836881T3
(es)
|
2013-07-30 |
2021-06-28 |
Janssen Sciences Ireland Unlimited Co |
Derivados de tieno[3,2-d]pirimidinas para el tratamiento de infecciones virales
|
|
EP2940022B1
(en)
*
|
2014-04-30 |
2020-09-02 |
Masarykova Univerzita |
Furopyridines as inhibitors of protein kinases
|
|
CA3002540C
(en)
|
2015-01-06 |
2023-11-07 |
Arena Pharmaceuticals, Inc. |
Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor
|
|
JP6838744B2
(ja)
|
2015-06-22 |
2021-03-03 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
Ｓ１Ｐ１レセプター関連障害における使用のための（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸（化合物１）の結晶性Ｌ−アルギニン塩
|
|
RU2699568C2
(ru)
*
|
2015-12-21 |
2019-09-06 |
Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" |
Лиганды транслокаторного белка TSPO, обладающие антидепрессивной и ноотропной активностью
|
|
MA45539A
(fr)
|
2016-07-01 |
2019-05-08 |
Janssen Sciences Ireland Unlimited Co |
Dihydropyranopyrimidines pour le traitement d'infections virales
|
|
SG10202010317VA
(en)
|
2016-09-29 |
2020-11-27 |
Janssen Sciences Ireland Unlimited Co |
Pyrimidine prodrugs for the treatment of viral infections and further diseases
|
|
BR112020002967A2
(pt)
|
2017-08-14 |
2020-08-11 |
Spruce Biosciences, Inc. |
antagonistas de receptor de fator de liberação de corticotropina
|
|
TW202415645A
(zh)
|
2018-03-01 |
2024-04-16 |
愛爾蘭商健生科學愛爾蘭無限公司 |
２，４－二胺基喹唑啉衍生物及其醫學用途
|
|
MX2020011344A
(es)
|
2018-04-27 |
2021-02-09 |
Spruce Biosciences Inc |
Métodos para tratar tumores en reposo suprarrenales testiculares y de ovarios.
|
|
JP7397011B2
(ja)
|
2018-06-06 |
2023-12-12 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
Ｓ１ｐ１受容体に関連する状態を治療する方法
|
|
CN108812546A
(zh)
*
|
2018-09-07 |
2018-11-16 |
四川省草原科学研究院 |
适于青藏高原地区牦牛运输减少应激的药物及使用方法
|
|
JP2023537598A
(ja)
|
2020-08-12 |
2023-09-04 |
スプルース バイオサイエンシーズ，インク． |
多嚢胞性卵巣症候群を処置するための方法および組成物
|
|
US11708372B2
(en)
|
2021-11-19 |
2023-07-25 |
Spruce Biosciences, Inc. |
Crystalline composition of tildacerfont and methods of use and preparation thereof
|